IL-23 secreted by myeloid cells drives castration-resistant prostate cancer
- 27 June 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 559 (7714), 363-369
- https://doi.org/10.1038/s41586-018-0266-0
Abstract
Patients with prostate cancer frequently show resistance to androgen-deprivation therapy, a condition known as castration-resistant prostate cancer (CRPC). Acquiring a better understanding of the mechanisms that control the development of CRPC remains an unmet clinical need. The well-established dependency of cancer cells on the tumour microenvironment indicates that the microenvironment might control the emergence of CRPC. Here we identify IL-23 produced by myeloid-derived suppressor cells (MDSCs) as a driver of CRPC in mice and patients with CRPC. Mechanistically, IL-23 secreted by MDSCs can activate the androgen receptor pathway in prostate tumour cells, promoting cell survival and proliferation in androgen-deprived conditions. Intra-tumour MDSC infiltration and IL-23 concentration are increased in blood and tumour samples from patients with CRPC. Antibody-mediated inactivation of IL-23 restored sensitivity to androgen-deprivation therapy in mice. Taken together, these results reveal that MDSCs promote CRPC by acting in a non-cell autonomous manner. Treatments that block IL-23 can oppose MDSC-mediated resistance to castration in prostate cancer and synergize with standard therapies.Keywords
This publication has 47 references indexed in Scilit:
- Bone morphogenetic protein‐6 induces castration resistance in prostate cancer cells through tumor infiltrating macrophagesCancer Science, 2013
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusionsGenome Biology, 2013
- Clinical significance of circulating interleukin‐23 as a prognostic factor in breast cancer patientsJournal of Cellular Biochemistry, 2012
- Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and CufflinksNature Protocols, 2012
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate CancerCancer Cell, 2011
- Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear CellsThe Journal of Immunology, 2010
- Diverse Targets of the Transcription Factor STAT3 Contribute to T Cell Pathogenicity and HomeostasisImmunity, 2010
- IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasisProceedings of the National Academy of Sciences of the United States of America, 2010
- B-cell-derived lymphotoxin promotes castration-resistant prostate cancerNature, 2010
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009